Fifteen years ago, advanced melanoma was usually lethal. But new treatments harnessing the immune system have increased survival so much that researchers haven’t completely been able to quantify it. An expert physician discusses the advances.
Guest:
- Dr. Philip Friedlander, Director, Melanoma Medical Oncology Program, Mt. Sinai, New York.
Stay in the loop! Follow us on Twitter and Instagram and like us on Facebook. Subscribe, rate and review on Apple Podcasts.
